A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer

Jeyalakshmi Kandhavelu, Kumar Subramanian, Vivash Naidoo, Giulia Sebastianelli, Phuong Doan, Saravanan Konda Mani, Hande Yapislar, Ebru Haciosmanoglu, Leman Arslan, Samed Ozer, Ramesh Thiyagarajan, Nuno R. Candeias, Clement Penny, Meenakshisundaram Kandhavelu, Akshaya Murugesan

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science